Overexpression of FGFR3 is associated with an immunologically cold, T cell-depleted phenotype, which contributes to a low ICI response rate in bladder cancer [58]—just like a low PD-L1 expression in an FGFR3-mutant scenario [59]. The gene discussed is CD274; the disease is urinary bladder carcinoma.